Alkermes plc. (ALKS): Cash & Equivalents
$388.57M
As of 2025-12-31
$511.53M
As of 2026-06-30
+9.9%
3-year compound annual growth
+7.3%
5-year compound annual growth
+7.9%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $388.57M | +33.5% | 2026-02-25, Balance as of period end |
| 2024-12-31 | $291.15M | -36.4% | 2026-02-25, Balance as of period end |
| 2023-12-31 | $457.47M | +56.4% | 2026-02-25, Balance as of period end |
| 2022-12-31 | $292.47M | -13.4% | 2024-02-21, Balance as of period end |
| 2021-12-31 | $337.54M | +23.7% | 2023-02-16, Balance as of period end |
| 2020-12-31 | $272.96M | +34.0% | 2022-02-16, Balance as of period end |
| 2019-12-31 | $203.77M | -23.6% | 2021-02-11, Balance as of period end |
| 2018-12-31 | $266.76M | +39.4% | 2020-02-13, Balance as of period end |
| 2017-12-31 | $191.30M | +2.6% | 2019-02-15, Balance as of period end |
| 2016-12-31 | $186.38M | +2.9% | 2018-02-16, Balance as of period end |
| 2015-12-31 | $181.11M | -19.2% | 2018-02-16, Balance as of period end |
| 2014-12-31 | $224.06M | +33.7% | 2017-02-17, Balance as of period end |
| 2013-12-31 | $167.56M | n/a | 2016-02-25, Balance as of period end |
| 2013-03-31 | $96.96M | +16.0% | 2015-02-24, Balance as of period end |
| 2012-03-31 | $83.60M | +117.7% | 2013-05-23, Balance as of period end |
| 2011-03-31 | $38.39M | -51.6% | 2013-05-23, Balance as of period end |
| 2010-03-31 | $79.32M | n/a | 2012-05-18, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Alkermes plc. (ALKS) | 2025-12-31 | $388.57M | +33.5% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $61.42M | -9.7% |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $984.65M | +26.3% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $195.00M | -38.9% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $63.87M | -34.8% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $177.69M | -44.4% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $801.28M | -27.4% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $198.69M | +98.7% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $372.26M | +53.8% |
Compare ALKS, PAHC, PTCT, INDV side by side · Screen every company in Pharmaceutical Preparations ↗